LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Respiratory Viruses Detected by Sensitive Molecular Technique

By LabMedica International staff writers
Posted on 15 Oct 2014
Image: The Diagnostics Respiratory Pathogens 21 PLUS (FTDRP) multiplex real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay kit (Photo courtesy of Fast-track Diagnostics).
Image: The Diagnostics Respiratory Pathogens 21 PLUS (FTDRP) multiplex real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay kit (Photo courtesy of Fast-track Diagnostics).
The diagnosis of respiratory viruses is presently based on virus isolation, detection of antigens, or serology—all of which are too time-consuming and, in some cases, have low sensitivity.

A real-time reverse transcriptase polymerase chain reaction (RT-PCR) detection method has been used to determine the frequency of a wide range of respiratory viruses in specimens from outpatients of all ages with acute respiratory infection (ARI).

Virologists at the Universidade Federal do Espírito Santo (Vitória, Brazil) collected nasopharyngeal aspirates (NPAs) from 162 patients of all ages who were attended at either emergency rooms or primary care units between August 2007 and August 2009. All samples were tested by indirect immunofluorescence assay (IIF) and Fast-Track Diagnostics Respiratory Pathogens 21 PLUS (FTDRP) multiplex real-time RT-PCR assay. Twenty-three respiratory pathogens, including 18 human respiratory viruses and 5 bacterial species, were tested using the multiplex protocol.

Seven respiratory viruses, respiratory syncytial virus (RSV), parainfluenza viruses 1-3 (PIV 1-3), influenza viruses A and B (Inf A, Inf B) and human adenovirus (HAdV) were screened in all specimens by IIF using the Respiratory Panel 1 Viral Screening & Identification Kit (Chemicon International, Millipore; Billerica, MA, USA). Multiplex real-time RT-PCR was performed using the FTDRP 21 plus (Fast-track Diagnostics; Sliema, Malta). Amplification was performed in the ABI 7500 real-time PCR system thermocycler (Applied Biosystems; Foster City, CA, USA).

The IIF method detected 33 positive specimens (20.4%) with the influenza virus the most common etiologic agent detected (23/33). Inf A and Inf B corresponded to 8% (13/162) and 6.2% (10/162) of the samples, respectively, and the IIF technique detected only single infections. The investigators reported that 88 (54.3%) specimens were positive for one or more respiratory viruses by multiplex real-time RT-PCR. The influenza virus (15.4%), human rhinovirus (HRV) (8%) and RSV (7.4%) were the viruses most frequently detected and accounted for one-third of the positive samples. Six cases of viral co-detection were observed, mainly involving RSV. The following bacteria were detected: Streptococcus pneumoniae in 43 samples, Staphylococcus aureus in 20, and 2 with Haemophilus influenza.

The authors concluded that the use of multiplex real-time RT-PCR increased the viral detection by 33.9% and revealed a larger number of respiratory viruses implicated in ARI cases, including the most recently described respiratory viruses, human bocavirus, Human metapneumovirus, influenza A (H1N1) pdm09 virus, Human coronavirus NL63 (HCoV) and HCoV HKU1. The study was published in the September 2014 issue of the Memorias do Instituto Oswaldo Cruz.

Related Links:

Universidade Federal do Espírito Santo
Chemicon International 
Fast-track Diagnostics


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more